"Antalgic Properties of Millimetric Waves on Chronical Pain: Is It Possible to Distinguish between Neuroplastic and Neuropathic Pain? A Report About 2 Fibromyalgia Cases"

Abstract

Millimetric wave (MMW) therapy was discovered in the 1970s' in USSR countries and used clinically for their hypoalgesic properties in various pain pathologies. Subsequently, these hypoalgesic properties were related to a central nervous system response following peripheral stimulation, mainly involving secretion of endorphins, as well as other neurotransmitters such as parasympathetic, DOPA, etc... In the more recent past (after 2010), the development of miniaturized solutions has allowed the personal use of MMWs -outside medical structures-in the management of chronic pain, and in particular neuroplastic or nociplastic pain, independently of any etiology. We report here on two cases of fibromyalgia, in which these two contributions to pain are involved. In each case, the patients experienced the use of a portable, wristband designed MMW system. The deliberate use of the device was first intended for wellness or stress relief purposes. The notion of the non-specificity of MMWs on chronic pain is discussed at the end of the article.